Camber Spine Expands Patent Portfolio with SPIRA Lateral 3.0

Camber Spine has received a notice of allowance from the United States Patent and Trademark Office (USPTO) for its SPIRA Lateral 3.0 interbody fusion implant.

UVDI-360 Room Sanitizer Inactivates SARS-CoV-2 at 12 Feet Distance in 5 Minutes

UltraViolet Devices Inc. (UVDI) has announced that its UVDI-360 Room Sanitizer achieved greater than 99.99%, or 4log10, inactivation of Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) in 5 minutes at a distance of 12 feet (3.65 meters).

oneSOURCE Creates Free Resource Page with Up-to-Date COVID-19 Vaccine Information

Today, oneSOURCE, an RLDatix company and leading healthcare management solution, announced a new COVID-19 vaccine resource page to assist healthcare professionals during the initial administration phases of the vaccine.

STERIS to Acquire Cantel Medical

STERIS plc and Cantel Medical Corp. announced that STERIS has signed a definitive agreement to acquire Cantel, through a U.S. subsidiary. Cantel is a global provider of infection prevention products and services primarily to endoscopy and dental Customers.

AMA Provides Ethics Guidance in the COVID-19 Pandemic

The COVID-19 pandemic makes exceptional demands on physicians in the United States as the number of cases continues to climb and the critical capacity of health systems is tested. Physicians and health care organizations find themselves facing significant ethical challenges.

The guidance of the American Medical Association’s (AMA) Code of Medical Ethics is as relevant in the context of a public health crisis as it is in more familiar circumstances of clinical practice. To help physicians address the challenges of COVID-19, the AMA has assembled a series of analyses that apply the Code to issues emerging in the pandemic.

“As the COVID-19 pandemic sweeps the country, physicians need not navigate these challenges alone,” said AMA President Patrice A. Harris, M.D., M.A. “The thoughtful deliberations of the Council on Ethical and Judicial Affairs embodied in the AMA Code of Medical Ethics are there to guide them.”

These issue-specific analyses range widely, offering guidance not only about allocating limited resources, but also responsible prescribing in the context of the pandemic, the importance of research ethics in the accelerated search for effective treatments for COVID-19, and issues of access to care and equity. New analyses are posted as questions continue to emerge:

As an editorially independent journal, the AMA Journal of Ethics has also created a COVID-19 Ethics Resource Center that includes expert analyses, visual assets, podcasts and video content.

These ethics resources are part of the comprehensive guidance from the AMA that help physicians navigate patient care as the COVID-19 pandemic evolves. Stay informed and updated on clinical information, guides, advocacy and medical ethics by connecting with the AMA COVID-19 Resource Center.



Submit a Comment

Your email address will not be published. Required fields are marked *